The association of CA125 tumor marker and hepatitis C.

被引：0
|
作者：
Yousif, EA [1 ]
Faris, VS [1 ]
Al-Hamad, T [1 ]
Kawalit, I [1 ]
Gelzayd, BC [1 ]
Maas, L [1 ]
机构：
[1] Providence Hosp, Southfield, MI 48037 USA
来源：
GASTROENTEROLOGY | 1999年 / 116卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G2349
引用
收藏
页码：A534 / A534
页数：1
相关论文
共 50 条
  • [21] Case presentation: role of CA125 as a tumor
    Eit, L. Y.
    Wuppalapati, P.
    Muotune, A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 121 : 62 - 63
  • [22] CLINICAL-VALUE OF A NEW SERUM TUMOR-MARKER CA125-II, IN GYNECOLOGIC DISEASE - COMPARISON WITH CA125
    TAMAKOSHI, K
    KIKKAWA, F
    HASEGAWA, N
    ISHIKAWA, H
    MIZUNO, K
    KAWAI, M
    TOMODA, Y
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1995, 39 (02) : 125 - 129
  • [23] Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125
    Clark, GF
    Morrison, JC
    Lattanzio, FA
    Yu, J
    Deng, YP
    Wong, NK
    Morris, HR
    Dell, A
    Patankar, MS
    GLYCOBIOLOGY, 2003, 13 (11) : 837 - 837
  • [24] The use and understanding of CA125 as a tumor marker for ovarian cancer: a questionnaire-based survey
    Moss, E. L.
    Hollingworth, J.
    Holland, M.
    Murphy, D. J.
    Fernando, I.
    Reynolds, T. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (03) : 439 - 445
  • [25] Prevalence of K-RAS mutations and CA125 tumor marker in patients with ovarian carcinoma
    Bagherlou, Nazanin
    Farajnia, Safar
    Zahri, Saber
    Tabrizi, Ali Dastranj
    Nazari, Atefeh
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2020, 11 (01) : 75 - 82
  • [26] THE USE OF CA125 AS A TUMOR-MARKER FOR ADENOCARCINOMAS OF ENDOCERVIX, ENDOMETRIUM AND FALLOPIAN-TUBE
    SCHARL, A
    CROMBACH, G
    MUSCH, H
    VIERBUCHEN, M
    BOLTE, A
    BRITISH JOURNAL OF CANCER, 1987, 56 (04) : 520 - 520
  • [27] Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125
    Patankar, MS
    Jing, Y
    Morrison, JC
    Belisle, JA
    Lattanzio, FA
    Deng, YP
    Wong, NK
    Morris, HR
    Dell, A
    Clark, GF
    GYNECOLOGIC ONCOLOGY, 2005, 99 (03) : 704 - 713
  • [28] THE ROLE OF THE CA125 MARKER AS A PROGNOSTIC FACTOR IN ENDOMETRIAL CANCER
    Cymbaluk-Ploska, A.
    Gargulinska, P.
    Kwiatkowski, S.
    Chudecka-Glaz, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A313 - A314
  • [29] CA125 AS A SERUM MARKER FOR POOR PROGNOSIS IN OVARIAN MALIGNANCIES
    ALVAREZ, RD
    TO, A
    BOOTS, LR
    SHINGLETON, HM
    HATCH, KD
    HUBBARD, J
    SOONG, SJ
    POTTER, ME
    GYNECOLOGIC ONCOLOGY, 1987, 26 (03) : 284 - 289
  • [30] TUMOR-MARKER ANTIGEN CA125 IN PANCREATIC-CANCER - A COMPARISON WITH CA19-9 AND CEA
    HAGLUND, C
    BRITISH JOURNAL OF CANCER, 1986, 54 (06) : 897 - 901
12345